Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on March 28, 2019, regarding events occurring on March 22, 2019. The filing discloses a strategic investment and acquisition agreement entered into by the Company.
Key Financial Metrics and Transaction Details
The filing details a Stock Purchase Agreement to acquire an approximately 45% ownership interest in Momentum Health Acquisition, Inc. (MHA), the parent of GlobalHealth, Inc., an Oklahoma-based health maintenance organization offering Medicare Advantage products.
- Total Consideration: Approximately $37.5 million in value.
- Cash Component: Approximately $15,000,000.
- Equity Component: Approximately $22,500,000 in Class A common stock.
- Share Calculation: The number of shares to be issued is based on the average of the last reported sale price of the Company's Class A common stock on the NYSE for the five consecutive trading days prior to closing.
- Flexibility: The Company retains the option to substitute cash for all or any portion of the equity consideration.
Note: This filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels for the reporting period.
Material Changes and Conditions
The transaction represents a material change in the Company's capital structure and business operations through the acquisition of a stake in a Medicare Advantage provider. The consummation of the transaction is subject to customary closing conditions, including:
- Approval by the Oklahoma Department of Insurance.
- Absence of legal impediments preventing the transaction.
- Accuracy of representations and warranties.
- Material compliance with obligations under the Purchase Agreement.
Upon closing, the Company or a subsidiary will enter into a master services agreement and a registration rights agreement with MHA.
Guidance, Risks, and Unusual Items
The filing contains forward-looking statements regarding the expected closing and consideration of the transaction. The Company explicitly disclaims any obligation to update these statements. Key risks identified include:
- Delays in or failure of the transaction to close.
- Potential litigation or other matters affecting the closing.
- Regulatory approval uncertainties.
The issuance of equity is exempt from registration under Section 4(a)(2) of the Securities Act as a transaction not involving a public offering. The shares will be restricted securities under Rule 144.
Investor Verification Checklist
- Verify the final share count and valuation based on the five-day average stock price at the time of closing.
- Confirm receipt of approval from the Oklahoma Department of Insurance.
- Review the attached Press Release (Exhibit 99.1) for additional management commentary on the strategic rationale.
- Monitor subsequent filings for updates on the closing status or any changes to the consideration mix (cash vs. equity).